Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BLRX - BioLineRx falls 9% as costs increase in second quarter


BLRX - BioLineRx falls 9% as costs increase in second quarter

  • biolinerx ( NASDAQ: BLRX ) is trading 9% lower as the company 's research and development costs and sales and marketing expenses rose.
  • The company's Q2 loss of -$0.01 and beat estimates by $0.08.
  • Sales and marketing expenses rose 250.9% Y/Y to $1.2M, primarily due to initiation of pre-commercialization activities related to Motixafortide, as well as an increase in market research.
  • Research and development costs rose 5% to $5.4M, hurt by an increase in expenses associated with the AGI-134 study.
  • Net financial expenses amounted to $0.3M, from $0.1M, a year earlier.
  • The Company held $43.2M in cash.

For further details see:

BioLineRx falls 9% as costs increase in second quarter
Stock Information

Company Name: BioLineRx Ltd.
Stock Symbol: BLRX
Market: NASDAQ
Website: biolinerx.com

Menu

BLRX BLRX Quote BLRX Short BLRX News BLRX Articles BLRX Message Board
Get BLRX Alerts

News, Short Squeeze, Breakout and More Instantly...